Nuzenio

Blossomhill Therapeutics

Blossomhill Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 16 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 02:04:27 GMTBlossomHill Therapeutics (BLSM): IPO Falls Flat After Aggressive Upsizing - Smartkarma
Fri, 07 Aug 2026 20:38:12 GMTLatham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO - Latham & Watkins LLP
Fri, 07 Aug 2026 20:34:34 GMTBlossomHill Therapeutics shares fall in debut after IPO - Investing.com
Fri, 07 Aug 2026 20:09:00 GMTBlossomHill Therapeutics, Clinical-Stage Oncology Drug Developer, Files for Nasdaq Global Select Market IPO - TradingView
Fri, 07 Aug 2026 19:11:07 GMTBlossomHill Therapeutics Shares Fall in Nasdaq Debut - Moomoo
Fri, 07 Aug 2026 17:52:10 GMTLatigo, BlossomHill cap busy week in biotech IPOs with nearly $500M haul - FirstWord Pharma

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Blossomhill Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

16 distinct publisher/source names are currently connected to this entity page.